• News
  • Sport
  • TV
  • Radio
  • Education
  • TV Licences
  • Contact Us
  • SOUTH AFRICA
  • POLITICS
  • BUSINESS
  • SPORT
  • AFRICA
  • WORLD
  • FEATURES
  • OPINION
No Result
View All Result
1
Home Sci-tech

China health app starts online sales of Pfizer’s Paxlovid for COVID treatment

13 December 2022, 1:42 PM  |
Reuters Reuters |  @SABCNews
Coronavirus disease (COVID-19) treatment pill Paxlovid is seen in a box, at Misericordia hospital in Grosseto, Italy, February 8, 2022.

Coronavirus disease (COVID-19) treatment pill Paxlovid is seen in a box, at Misericordia hospital in Grosseto, Italy, February 8, 2022.

Image: Reuters

Coronavirus disease (COVID-19) treatment pill Paxlovid is seen in a box, at Misericordia hospital in Grosseto, Italy, February 8, 2022.

 A Chinese healthcare platform has started selling Pfizer’s (PFE.N) oral COVID treatment pill Paxlovid in what appears to be the first retail sale of the drug in the country, as China braces for a surge in COVID patients.

The medication sold out just over half an hour after the listing was reported in the media, the platform’s customer service said, underscoring surging demand for COVID and flu medicines in China.

Three years into the pandemic, China began pivoting away from its signature ‘zero COVID’ policy just this month after historic protests against economically-damaging curbs that had been repeatedly championed by President Xi Jinping.

The sudden loosening of restrictions has sparked long queues outside fever clinics in a worrying sign that a wave of infections is building, even though official tallies of new cases have trended lower recently as authorities eased back on testing.

Healthcare company 111.inc has started selling Paxlovid for 2,980 yuan ($426.80) per box, the sales page on the app showed on Tuesday.

People can purchase the medication on the app if they submit a positive COVID-19 test result.

It was not clear how many boxes were sold and when sales would resume, or whether other retailers have also started selling the drug.

Pfizer did not immediately reply to a Reuters’ request for comment.

The launch of retail sales of Paxlovid in China could be a major earnings boost to Pfizer, which has faced some investor concerns about a sharp hit to its topline from an expected decline in COVID vaccine demand.

Paxlovid, which was approved by China in February, has been available through hospitals to treat high-risk patients in several provinces, Chinese media Yicai reported in March.

Pfizer said on Monday that annual revenue from its messenger RNA (mRNA) vaccine portfolio could reach $10 billion to $15 billion by 2030.

Its COVID-19 vaccine, jointly developed with its German partner BioNTech (22UAy.DE) using mRNA technology, is not approved for use in China.

Share article
Tags: PfizerCOVID-19Paxlovid
Previous Post

Steenhuisen says he hopes Parliament will hold Ramaphosa accountable

Next Post

LIVE: NA debates Section 89 Independent Panel Report into Phala Phala

Related Posts

A tap with a droplet of water.

UN Water Conference kicks off as world marks World Water Day

22 March 2023, 9:30 PM
Rahima Moosa Mother and Child Hospital, the Old Coronation Hospital.

“Report exposes state of Gauteng public health facilities”

15 March 2023, 11:09 AM
Members of Nehawu on strike

Phaahla links four deaths to Nehawu’s wage strike

9 March 2023, 1:00 PM
Silhouettes of mobile users are seen next to a screen projection of Instagram logo in this picture illustration taken March 28, 2018.

Instagram down for thousands of users globally

9 March 2023, 7:33 AM
[File Image]: A nurse at one of South Africa's hospital during the height of the coronavirus pandemic.

Patients suffer as health workers strike

9 March 2023, 7:30 AM
A representation of depression

Negative impact of rolling blackouts on mental health

7 March 2023, 5:56 PM
Next Post

LIVE: NA debates Section 89 Independent Panel Report into Phala Phala

Most Viewed

  • 24hrs
  • Week
  • Month
  • DENOSA defends nurses for placing newborns in boxes
  • North West Health probes why newborn babies were placed in boxes
  • eThekwini residents face higher stages of load shedding from Thursday
  • Namibia declares outbreak of Crimean-Congo fever after patient dies
  • Pending court cases interfering with my duties: AmaZulu King
  • Dr Nandipha’s looks during court appearances under the spotlight
  • Experts raise caution over Prime energy drink craze
  • NW residents plunged into darkness after burning of power station
  • 108-carat ‘fancy intense pink’ diamond discovered in Lesotho
  • Dr Nandipha Magudumana, co-accused in Thabo Bester’s escape to apply for bail
  • DENOSA defends nurses for placing newborns in boxes
  • EFF Limpopo councillor gunned down at his home
  • Pirates win Nedbank Cup final
  • Cholera outbreak death toll rises to 24
  • New DA leader in Limpopo to prioritise reuniting members

LATEST

Water tanker provides water to Hammanskraal
  • Cholera outbreak
  • South Africa

Hammanskraal residents call on President to visit


A man is pictured refilling bottles from a water tanker.
  • Cholera outbreak
  • South Africa

Ventersburg residents call for clean drinking water amid cholera outbreak


File image: Tourists on a game drive.
  • Business

Limpopo Tourism Agency launches it’s winter campaign


(File Image) Al Shabaab militants seen
  • Africa

Uganda confirms casualties among country’s soldiers in Somali attack


ANC media briefing
  • Politics

LIVE: ANC media briefing on NWC’s visit to North West


A water tanker distributing water to Hammanskraal residents.
  • Cholera outbreak
  • South Africa

CORRECTION: Ramaphosa plans to visit cholera-hit Hammanskraal


Weather

  • About the SABC
  • Contact Us
  • Jobs
  • Advertise
  • Disclaimer
  • Site Map

SABC © 2023

No Result
View All Result
  • SOUTH AFRICA
  • POLITICS
  • BUSINESS
  • SPORT
  • AFRICA
  • WORLD
  • FEATURES
  • OPINION

© 2023

Previous Steenhuisen says he hopes Parliament will hold Ramaphosa accountable
Next LIVE: NA debates Section 89 Independent Panel Report into Phala Phala